Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists - Takeaways - MDSpire

Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists

  • By

  • Yuanli Li

  • Changxin Chen

  • Chengdang Wang

  • April 27, 2026

  • 0 min

Share

  • 1

    A nationwide survey of 615 IBD specialists in China revealed that 90.4% prescribe 5-ASA for Crohn's disease patients.

  • 2

    5-ASA is primarily used for mild Crohn's disease, colonic involvement, and non-stricturing, non-penetrating disease phenotypes.

  • 3

    Despite international guidelines advising against its use, 5-ASA remains commonly prescribed, highlighting a significant evidence-practice gap.

  • 4

    The main reasons for prescribing 5-ASA include its favorable safety profile and perceived efficacy in mild cases.

  • 5

    The study underscores the need for targeted continuing medical education to align clinical practice with evidence-based guidelines.

Original Source(s)

Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists

  • by Yuanli Li, Changxin Chen, Chengdang Wang

  • April 27, 2026

Related Content

Renal Conditions Associated with Inflammatory Bowel Disease: Exploring Clinical Links, Shared Mechanisms, and Management Approaches

Sex-related peripheral immune profile in ulcerative colitis: links to fatigue

Link Between Blastocystis Subtypes 3 and 4 and Intestinal Inflammation as Well as Metronidazole Efficacy in Symptomatic Individuals